» Articles » PMID: 26911846

Early Lipid Changes in Acute Kidney Injury Using SWATH Lipidomics Coupled with MALDI Tissue Imaging

Overview
Specialties Nephrology
Physiology
Date 2016 Feb 26
PMID 26911846
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Acute kidney injury (AKI) is one of the leading causes of in-hospital morbidity and mortality, particularly in critically ill patients. Although our understanding of AKI at the molecular level remains limited due to its complex pathophysiology, recent advances in both quantitative and spatial mass spectrometric approaches offer new opportunities to assess the significance of renal metabolomic changes in AKI models. In this study, we evaluated lipid changes in early ischemia-reperfusion (IR)-related AKI in mice by using sequential window acquisition of all theoretical spectra (SWATH)-mass spectrometry (MS) lipidomics. We found a significant increase in two abundant ether-linked phospholipids following IR at 6 h postinjury, a plasmanyl choline, phosphatidylcholine (PC) O-38:1 (O-18:0, 20:1), and a plasmalogen, phosphatidylethanolamine (PE) O-42:3 (O-20:1, 22:2). Both of these lipids correlated with the severity of AKI as measured by plasma creatinine. In addition to many more renal lipid changes associated with more severe AKI, PC O-38:1 elevations were maintained at 24 h post-IR, while renal PE O-42:3 levels decreased, as were all ether PEs detected by SWATH-MS at this later time point. To further assess the significance of this early increase in PC O-38:1, we used matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI-IMS) to determine that it occurred in proximal tubules, a region of the kidney that is most prone to IR injury and also rich in the rate-limiting enzymes involved in ether-linked phospholipid biosynthesis. Use of SWATH-MS lipidomics in conjunction with MALDI-IMS for lipid localization will help in elucidating the role of lipids in the pathobiology of AKI.

Citing Articles

Metabolomic and Lipidomic Profiling for Pre-Transplant Assessment of Delayed Graft Function Risk Using Chemical Biopsy with Microextraction Probes.

Warmuzinska N, Luczykowski K, Stryjak I, Wojtal E, Woderska-Jasinska A, Masztalerz M Int J Mol Sci. 2025; 25(24.

PMID: 39769265 PMC: 11728147. DOI: 10.3390/ijms252413502.


PGC-1-mediated imbalance of mitochondria-lipid droplet homeostasis in neomycin-induced ototoxicity and nephrotoxicity.

Chen B, Cheng C, Wu Y, Li S, Han M, Zhen L Acta Pharm Sin B. 2024; 14(10):4413-4430.

PMID: 39525588 PMC: 11544387. DOI: 10.1016/j.apsb.2024.05.024.


Application of spatial-omics to the classification of kidney biopsy samples in transplantation.

Tasca P, van den Berg B, Rabelink T, Wang G, Heijs B, van Kooten C Nat Rev Nephrol. 2024; 20(11):755-766.

PMID: 38965417 DOI: 10.1038/s41581-024-00861-x.


Exploring therapeutic mechanisms of Chuan Huang Fang-II in the treatment of acute kidney injury on chronic kidney disease patients from the perspective of lipidomics.

Chen L, Wang Q, Li T, Li L, Wang C, Xu B Ren Fail. 2024; 46(1):2356021.

PMID: 38785301 PMC: 11132756. DOI: 10.1080/0886022X.2024.2356021.


The impact of normothermic and hypothermic preservation methods on kidney lipidome-comparative study using chemical biopsy with microextraction probes.

Warmuzinska N, Luczykowski K, Stryjak I, Rosales-Solano H, Urbanellis P, Pawliszyn J Front Mol Biosci. 2024; 11:1341108.

PMID: 38784665 PMC: 11112113. DOI: 10.3389/fmolb.2024.1341108.


References
1.
Uehara T, Horinouchi A, Morikawa Y, Tonomura Y, Minami K, Ono A . Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats. J Appl Toxicol. 2013; 34(10):1087-95. DOI: 10.1002/jat.2933. View

2.
Portilla D . Role of fatty acid beta-oxidation and calcium-independent phospholipase A2 in ischemic acute renal failure. Curr Opin Nephrol Hypertens. 1999; 8(4):473-7. DOI: 10.1097/00041552-199907000-00012. View

3.
. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001; 69(3):89-95. DOI: 10.1067/mcp.2001.113989. View

4.
Liu Y, Yan S, Ji C, Dai W, Hu W, Zhang W . Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury. Kidney Blood Press Res. 2012; 35(5):373-81. DOI: 10.1159/000336171. View

5.
Ling X, Mellins E, Sylvester K, Cohen H . Urine peptidomics for clinical biomarker discovery. Adv Clin Chem. 2010; 51:181-213. DOI: 10.1016/s0065-2423(10)51007-2. View